G. Massa

Details der Publikationsliste

Zeitraum

1987 - 2008

Anzahl

26

Co-Autoren

Undulation textures at the phase transitions of some alkyloxybenzoic acids (2008)

Sparavigna, A., Mello, A., Massa, G.

We observed undulated smectic textures for some compounds of the 4,n-alkyloxybenzoic (nOBAC) acid series, at transitions between the smectic and the isotropic phase and between the smectic and...

Effect of 2 years of high-dose growth hormone therapy on cognitive and psychosocial development in short children born small for gestational age (2007)

Vanderfaeillie, J, Froidecoeur, C, Thomas, Muriel, Massa, G, Tenoutasse, S, ...

Objective and design: Children born small for gestational age (SGA) are not only at risk for short stature, but also for neurodevelopmental and behavioral problems. In this study, we analyzed the...

Effect of 2 years of high-dose growth hormone therapy on cognitive and psychosocial development in short children born small for gestational age (2007)

Lagrou, K., Vanderfaeillie, J., Froidecocur, C., Thomas, M., Massa, G., Tenoutasse, S., ...

Objective and design: Children born small for gestational age (SGA) are not only at risk for short stature, but also for neurodevelopmental and behavioral problems. In this study, we analyzed the...

Prevalence and demographic features of childhood growth hormone deficiency in Belgium during the period 1986-2001 (2004)

Massa, G, Craen, M, Bourguignon, J P, Heinrichs, C, ...

OBJECTIVE: Since the availability of recombinant human growth hormone (rhGH) all children with growth hormone deficiency (GHD) living in Belgium are offered rhGH treatment after approval by a...

Growth hormone (GH) secretion in patients with childhood-onset GH deficiency: Retesting after one year of therapy and at final height (2003)

Massa, G, Maes, M, Beckers, D, Craen, M, Francois, I, ...

Background. Recent studies have shown that many patients treated with growth hormone (GH) during childhood because of idiopathic GH deficiency (GHD) are no longer GH deficient when retested after...

Final height in children with idiopathic growth hormone deficiency treated with recombinant human growth hormone: The Belgian experience (2001)

Massa, G, Bourguignon, JP, Craen, M, De Schepper, J, ...

Background: The growth response to recombinant hGH (rhGH) treatment and final height of 61 Belgian children (32 boys) with idiopathic growth hormone deficiency (GHD) were studied. Patients/Methods:...

Opposite effects of growth hormone and estrogens on the pregnancy zone protein serum levels in children and adolescents (1993)

Massa, G, ...

Serum levels of pregnancy zone protein were measured in children with growth hormone deficiency and in girls with Turner syndrome, before and during treatment with recombinant human growth hormone...

Intelligence, behaviour and psychosocial development in Turner syndrome. A cross-sectional study of 50 pre-adolescent and adolescent girls (4-20 years) (1993)

Massa, G, Vanderschueren-Lodeweyckx, M

In this paper we report the findings and data on a cross-sectional study of 50 pre-adolescent and adolescent girls with Turner syndrome. We confirm the presence of a typical cognitive profile in the...

Growth hormone deficiency in a girl with the Cohen syndrome.

Massa, G, Dooms, L, Vanderschueren-Lodeweyckx, M

A girl with the Cohen syndrome and isolated growth hormone deficiency is described. Treatment with biosynthetic human growth hormone resulted in marked catch up growth to normal stature. It is...

Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections

Sas, T., Keizer-Schrama, S, Stijnen, T., Van Teunenbroek, A, Hokken-Koelega, A, Waelkens, J, ...

OBJECTIVES—To study final height in girls with Turner's syndrome treated with once or twice daily injections of growth hormone (GH) in combination with low dose ethinyl oestradiol.
DESIGN—Until...

Cytotoxic effect of dose and schedule on normal murine hematopoietic progenitor cells following the administration of 4'-deoxydoxorubicin.

Pannacciulli, I., Muzzulini, C., Massa, G., Bogliolo, G.

In an experimental setting, 4'-deoxydoxorubicin (4'-deoxy-DX) shows minimal cardiotoxicity as well as the marked antitumoral activity shown by doxorubicin, its parent compound. In this experimental...